Wire · opportunities
Generative AI Is Coming to Medical Devices. FDA Is Already Thinking About What Comes Next.
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
The FDA has released a discussion paper exploring regulatory approaches for generative AI-enabled medical devices, highlighting challenges in testing, performance management, and adapting to AI updates in healthcare products.
This Wire brief sits within Fusion42's coverage of Medtech, and 14 sources have reported it between 18 Aug 2026 and 15 Sep 2026.
◆ ◆ The Wire takeaway
Your next product updates must prove ongoing safety as AI models change after market launch. Start building real-world performance monitoring and AI provider agreements into your development process.
◆ Coverage
14 sources · first reported 18 Aug 2026 · latest 15 Sep 2026
◆ Related on Wire
◆ Topics